$63.68
▲ +0.1% Today
as of Aug 5, 16:46 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 2
● 23
▼ 0
AstraZeneca-BMY megadeal talk sparks huge market rift
BMY or AMGN: Which Is the Better Value Stock Right Now?
Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?
Overview
52-week range
$43
$63
100% of range
Avg surprise (last 2)
+27.8%
Avg reaction (last 1)
+0.3%
100% positive
Latest IV / EM
36%
EM ±2.1% · $64 · Aug 7
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $1.31 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $1.08 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.46 | $1.07 | +36.5% | — | — | earnings |
| Thu Apr 24, 2025 | Mar/2025 | $1.80 | $1.51 | +19.2% | — | +0.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.60 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.83 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-5.89 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.93 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.99 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.49B | — | $12.22B | $12.27B | $11.20B | — | $11.89B | $12.20B |
| Cost of revenue | $3.42B | — | $3.44B | $3.37B | $3.03B | — | $2.96B | $3.27B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $2.68B | — | $2.20B | $1.31B | $2.46B | — | $1.21B | $1.68B |
| EPS (diluted) | $1.31 | — | $1.08 | $0.64 | $1.20 | — | $0.60 | $0.83 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.57B | $10.21B | $15.73B | $12.60B | $10.88B | $10.35B | $7.89B | $6.29B |
| Inventory | $2.76B | $2.69B | $2.76B | $2.74B | $2.67B | $2.56B | $3.33B | $3.08B |
| Total current assets | $27.21B | $29.39B | $35.63B | $33.22B | $30.78B | $29.78B | $28.07B | $26.89B |
| Total assets | $86.48B | $90.04B | $96.89B | $94.68B | $92.43B | $92.60B | $93.67B | $94.65B |
| Long-term debt | $42.15B | $42.85B | $44.47B | $44.47B | $46.16B | $47.60B | $48.67B | $48.86B |
| Total liabilities | $66.37B | $71.53B | $78.29B | $77.19B | $74.98B | $76.22B | $76.47B | $77.58B |
| Total equity | $20.07B | $18.47B | $18.55B | $17.43B | $17.39B | $16.34B | $17.14B | $17.02B |